1. Improvement effect of compound Ento-PB on oxazolone-induced ulcerative colitis in rats.
- Author
-
Fan Z, Chen J, Wei J, Yang Z, Xiao H, and Liu H
- Subjects
- Animals, Male, Drugs, Chinese Herbal pharmacology, Drugs, Chinese Herbal therapeutic use, Disease Models, Animal, Tumor Necrosis Factor-alpha analysis, Tumor Necrosis Factor-alpha metabolism, Rats, Sprague-Dawley, Intestinal Mucosa drug effects, Intestinal Mucosa pathology, Intestinal Mucosa metabolism, Rats, Enzyme-Linked Immunosorbent Assay, Epidermal Growth Factor analysis, Cytokines metabolism, Interleukin-13 analysis, Nitric Oxide Synthase Type II metabolism, Nitric Oxide Synthase Type II analysis, Reproducibility of Results, Treatment Outcome, Colitis, Ulcerative chemically induced, Colitis, Ulcerative drug therapy, Colitis, Ulcerative pathology, Oxazolone, Colon drug effects, Colon pathology, Colon metabolism, Peroxidase analysis, Peroxidase metabolism
- Abstract
Purpose: To investigate the impact of the Chinese medicine compound Ento-PB on oxazolone (OXZ)-induced ulcerative colitis (UC) in rats., Methods: UC rats induced by OXZ were treated with Ento-PB. The damage to the colon was assessed using several measures, including the disease activity index (DAI), colon length, colon weight/length ratio, colonic mucosal damage index, and histological score. The levels of interleukin-4 (IL-4), interleukin-10 (IL-10), interleukin-13 (IL-13), epidermal growth factor (EGF), inducible nitric oxide synthase, and total nitric oxide synthase (tNOS) in rat serum, as well as the levels of tumor necrosis factor-α (TNF-α) and myeloperoxidase (MPO) in rat colon tissue, were determined using enzyme-linked immunosorbent assay and conventional kits., Results: After being treated with Ento-PB, the DAI score and macroscopic lesion score of OXZ-induced UC rats were significantly reduced. Ento-PB prevented the shortening of rat colons, reduced the ratio of colon weight to length, and improved colon tissue lesions. Meanwhile, Ento-PB could significantly inhibit the activities of proinflammatory cytokines TNF-α, IL-13, and MPO, as well as tNOS and iNOS, while upregulating the expression of anti-inflammatory cytokines IL-4 and IL-10. Moreover, a significant increase in the expression level of EGF was observed in UC rats treated with Ento-PB, indicating that Ento-PB could enhance the repair of damaged intestinal epithelial tissue., Conclusions: Ento-PB demonstrates significant anti-UC activities in OXZ-induced UC rats by regulating the expression levels of inflammatory factors and promoting the repair of colon tissue. This study provides scientific evidence to support the further development of Ento-PB.
- Published
- 2024
- Full Text
- View/download PDF